Tan Tock Seng Hospital (TTSH) and biomedical technology company Buzud are working on an AI or artificial intelligence-enabled ...

Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.

California’s low-cost insulin plan is more than a year behind schedule with no clear timeline. Advocates say the delay is ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

Tv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

Biocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

Growth hormone injections deliver a synthetic growth hormone to the body to treat hormone deficiencies and other health ...

The National Agency for Food and Drug Administration and Control has raised the alarm over the illegal circulation and ...